Position in SCLX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$79
-$6 QoQ
Shares Held
12
+71.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in SCLX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026FMR LLC holds $65,159,031,370 across 17 Drug Manufacturers - General names. SCLX ranks #17 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
26,341,031 | $24,227,690,080 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
71,906,290 | $10,021,579,632 | |
| 3 | JNJ |
Johnson & Johnson
|
24,771,828 | $6,055,225,633 | |
| 4 | AZN |
Astrazeneca PLC
|
29,601,724 | $5,838,052,004 | |
| 5 | MRK |
Merck & Co., Inc.
|
44,516,010 | $5,354,830,840 | |
| 6 | ABBV |
AbbVie Inc.
|
21,762,703 | $4,733,170,273 | |
| 7 | GSK |
GSK plc
|
67,661,646 | $3,734,246,242 | |
| 8 | BIIB |
Biogen Inc.
|
12,807,541 | $2,348,006,489 |
All Filings in SCLX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $79 | 12 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $85 | 7 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $137 | 7 | Shares | Defined | 2025-11-13 | |
| No filing history on record for this holder in this stock. | ||||||